Harbert halfway there with $125M investment fund

Good news for medical device companies, diagnostics startups and other healthcare companies: Harbert Venture Partners has passed the 50% mark in its bid to establish a new, $125 million investment fund.

MedCity News reports on the news regarding what will be the VC firm's third fund. So far, the fund has raised more than $76.8 million and has about $48.1 million to go, according to an SEC filing. Based in the southeastern U.S., Harbert focuses on areas including diagnostics, medical devices, healthcare IT and healthcare services, according to the story.

Among the company's device and diagnostic portfolio companies: Ion Healthcare, which offers sleep apnea diagnostics services; nContact, which is developing technology to treat atrial fibrillation using radiofrequency ablation; and Innovative Biosciences, a diagnostics company dealing with infectious diseases.

Harbert has invested more than $150 million in 24 early-stage healthcare and IT companies, the article notes.

- here's the story
- check out the SEC filing

Suggested Articles

The clinical testing giant LabCorp will now begin rolling out a blood test for lung cancer developed by Resolution Bioscience.

Cognoa aims to equip pediatricians with an AI-powered app that can spot the signs of autism, allowing them to diagnose in the doctor's office.

Longitude Capital invests in what its founders call “transformative healthcare companies," working in areas they hope will increase quality of life.